Skip to main content
ALGS logo

ALGS · Aligos Therapeutics, Inc.

$4.33 +0.08 (+1.88%)
Market Cap
$15.25M
Shares
3.59M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 34
Total Value: $20,614,960
Total Shares: 2,775,186

Institutional Ownership Trend

8 quarters

Holder Concentration

Across 34 13F filers
Top Holder
16.0%
Sep 2024 → Mar 2026 · range 14.1% – 20.1%
of institutional value
Top 5
60.5%
Sep 2024 → Mar 2026 · range 57.0% – 70.3%
of institutional value
Top 10
85.3%
Sep 2024 → Mar 2026 · range 83.0% – 92.1%
of institutional value
HHI
933
Sep 2024 → Mar 2026 · range 851 – 1,157
Broadly held
Showing 34 of 34
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1799448 CUSIP 01626L204 13F (30d) 3 filings 3 filers Visit website